New Hope for Severe Asthma: Biologics Offer Relief
Millions struggle with chronic asthma, experiencing limitations despite regular inhalers. Biologics, a new class of targeted therapies, offer promising relief.
Traditional treatments like inhaled corticosteroids (ICS) manage symptoms, but some patients with severe asthma experience uncontrolled attacks. Biologics address this gap.
How Biologics Work:
Unlike traditional medications, biologics target specific parts of the immune system involved in asthma inflammation.
Available Biologics:
- Omalizumab (Xolair) targets a protein triggering allergic reactions.
- Dupilumab (Dupixent) blocks a protein involved in inflammation (eosinophilic asthma).
- Mepolizumab (Nucala) and Reslizumab (Cinqair) target different inflammatory proteins.
- Benralizumab (Fasenra) targets a specific white blood cell in allergic asthma.
Benefits of Biologics:
- Reduced asthma attack frequency and severity
- Improved lung function
- Less reliance on oral steroids
- Enhanced quality of life
Considerations:
- Biologics are typically injectable (doctor's office or home).
- Discuss potential side effects with your doctor.
- Biologics manage, not cure, asthma.
- Talk to your doctor about insurance coverage and costs.
Severe asthma can be debilitating. Biologics offer a new path to better breathing and a fuller life. Consult your doctor to see if biologics are right for you.
Disclaimer: This article provides information only and is not a substitute for medical advice. Please consult your healthcare professional for diagnosis and treatment.
For further reading, check out this study: annallergy.org.
Also, see how others are coping with severe asthma on Instagram: instagram.com.
Learn more about asthma and allergies: breathesleepmd.com.